Breaching the Blood–Brain Tumor Barrier for Tumor Therapy

por Marcucci, Fabrizio, Corti, Angelo, Ferreri, Andrés J. M.
Publicado 2021

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α

por Corti, Angelo, Calimeri, Teresa, Curnis, Flavio, Ferreri, Andres J. M.
Publicado 2022

Prevention and management of secondary central nervous system lymphoma

por Bobillo, Sabela, Khwaja, Jahanzaib, Ferreri, Andrés J.M., Cwynarski, Kate
Publicado 2022

Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review

por Steffanoni, Sara, Calimeri, Teresa, Marktel, Sarah, Nitti, Rosamaria, Foppoli, Marco, Ferreri, Andrés J. M.
Publicado 2023

Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis

por Ferreri, Andrés J. M., Zinzani, Pier Luigi, Messina, Carlo, Valsecchi, Diletta, Rendace, Maria Chiara, Premoli, Eleonora, Giacomini, Elisa, Veronesi, Chiara, Degli Esposti, Luca, Di Matteo, Paola
Publicado 2023

Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients

por Destito, Michela, Marzullo, Aldo, Leone, Riccardo, Zaffino, Paolo, Steffanoni, Sara, Erbella, Federico, Calimeri, Francesco, Anzalone, Nicoletta, De Momi, Elena, Ferreri, Andrés J. M., Calimeri, Teresa, Spadea, Maria Francesca
Publicado 2023

Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma

por She, Ziyu, Marzullo, Aldo, Destito, Michela, Spadea, Maria Francesca, Leone, Riccardo, Anzalone, Nicoletta, Steffanoni, Sara, Erbella, Federico, Ferreri, Andrés J. M., Ferrigno, Giancarlo, Calimeri, Teresa, De Momi, Elena
Publicado 2023

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III...

por Schorb, Elisabeth, Finke, Juergen, Ferreri, Andrés J. M., Ihorst, Gabriele, Mikesch, Kristina, Kasenda, Benjamin, Fritsch, Kristina, Fricker, Heidi, Burger, Elvira, Grishina, Olga, Valk, Elke, Zucca, Emanuele, Illerhaus, Gerald
Publicado 2016

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial

por Scarfò, Lydia, Ferrari, Silvia, Frustaci, Anna Maria, Tani, Monica, Bari, Alessia, Scarano, Eloise, Colia, Maria, Ranghetti, Pamela, Angelillo, Piera, Ronchi, Paola, Ponzoni, Maurilio, Ferreri, Andrés J. M., Ghia, Paolo
Publicado 2022

IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma

por Pirosa, Maria Cristina, Sassone, Marianna, Kiesewetter, Barbara, Guillermo, Armando Lopez, Devizzi, Liliana, Domènech, Eva Domingo, Tucci, Alessandra, Mannina, Donato, Merli, Michele, Salar, Antonio, Visco, Carlo, Esposito, Fabiana, Bonomini, Luisella, Zucca, Emanuele, Ferreri, Andrés J. M., Raderer, Markus
Publicado 2022

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma

por Ferreri, Andrés J.M., Angelillo, Piera, Erbella, Federico, Cattaneo, Chiara, Verga, Luisa, Lleshi, Arben, Allione, Bernardino, Ponzoni, Maurilio, Facchetti, Fabio, Pagani, Chiara, Foppoli, Marco, Pecciarini, Lorenza, Sassone, Marianna, Steffanoni, Sara, Flospergher, Elena, Rossi, Giuseppe, Spina, Michele, Re, Alessandro
Publicado 2022

Impact of COVID-19 Pandemic Waves on Outcomes of Patients with Previously Untreated Advanced Follicular Lymphoma Enrolled in the Urban Ambispective Study in Italy

por Pinto, Antonio, Guardalben, Emanuele, Battista, Marica, Gazzoli, Giulia Chiara, Merli, Michele, Chiarenza, Annalisa, Perrone, Tommasina, Guarini, Attilio, Di Renzo, Nicola, Visco, Carlo, Tafuri, Agostino, Murru, Roberta, Ferrara, Felicetto, Olivieri, Jacopo, Olivieri, Attilio, Ferreri, Andrés J M, Ladetto, Marco, Zinzani, Pier Luigi, Arcaini, Luca, Gritti, Giuseppe
Publicado 2022

Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial

por Hancock, Barry W, Qian, Wendi, Linch, David, Delchier, Jean-Charles, Smith, Paul, Jakupovic, Ira, Burton, Cathy, Souhami, Robert, Wotherspoon, Andrew, Copie-Bergman, Christiane, Capella, Carlo, Traulle, Catherine, Levy, Michael, Cortelazzo, Sergio, Ferreri, Andres J M, Ambrosetti, Achille, Pinotti, Graziella, Martinelli, Giovanni, Vitolo, Umberto, Cavalli, Franco, Gisselbrecht, Christian, Zucca, Emanuele
Publicado 2009

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term

por Cortelazzo, Sergio, Mian, Michael, Evangelista, Andrea, Devizzi, Liliana, Corradini, Paolo, Magni, Michele, Ladetto, Marco, Ferrero, Simone, Rossi, Andrea, Barbui, Anna Maria, Patti, Caterina, Costa, Alessandro, Vitolo, Umberto, Chiappella, Annalisa, Benedetti, Fabio, Ferreri, Andrés J. M., Nicoli, Paolo, Rigacci, Luigi, Castellino, Claudia, Gianni, Alessandro M., Rambaldi, Alessandro, Tarella, Corrado
Publicado 2021

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

por Visco, Carlo, Wang, Jinfen, Tisi, Maria Chiara, Deng, Lijuan, D'Amore, Emanuele S G, Tzankov, Alexandar, Montes-Moreno, Santiago, Dybkær, Karen, Bhagat, Govind, Hsi, Eric D, van Krieken, J Han, Ponzoni, Maurilio, Ferreri, Andrés J M, Møller, Michael B, Piris, Miguel A, Medeiros, L Jeffrey, Xu-Monette, Zijun Y, Young, Ken H
Publicado 2017

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus–Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi

por Merli, Michele, Rattotti, Sara, Spina, Michele, Re, Francesca, Motta, Marina, Piazza, Francesco, Orsucci, Lorella, Ferreri, Andrés J.M., Perbellini, Omar, Dodero, Anna, Vallisa, Daniele, Pulsoni, Alessandro, Santoro, Armando, Sacchi, Paolo, Zuccaro, Valentina, Chimienti, Emanuela, Russo, Filomena, Visco, Carlo, Zignego, Anna Linda, Marcheselli, Luigi, Passamonti, Francesco, Luminari, Stefano, Paulli, Marco, Bruno, Raffaele, Arcaini, Luca
Publicado 2022

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (I...

por Barajas, Ramon F, Politi, Letterio S, Anzalone, Nicoletta, Schöder, Heiko, Fox, Christopher P, Boxerman, Jerrold L, Kaufmann, Timothy J, Quarles, C Chad, Ellingson, Benjamin M, Auer, Dorothee, Andronesi, Ovidiu C, Ferreri, Andres J M, Mrugala, Maciej M, Grommes, Christian, Neuwelt, Edward A, Ambady, Prakash, Rubenstein, James L, Illerhaus, Gerald, Nagane, Motoo, Batchelor, Tracy T, Hu, Leland S
Publicado 2021

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET‐2‐adapted...

por Romano, Alessandra, Pavoni, Chiara, Di Raimondo, Francesco, Tarella, Corrado, Viviani, Simonetta, Rossi, Andrea, Patti, Caterina, Picardi, Marco, Cantonetti, Maria, La Nasa, Giorgio, Trentin, Livio, Bolis, Silvia, Zoli, Valerio, Gavarotti, Paolo, Corradini, Paolo, Cimminiello, Michele, Schiavotto, Corrado, Parvis, Guido, Zanotti, Roberta, Gini, Guido, Ferreri, Andrés J. M., Viero, Piera, Chauvie, Stephane, Biggi, Alberto, Massimo Gianni, Alessandro, Gallamini, Andrea, Rambaldi, Alessandro
Publicado 2020

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial

por Fox, Christopher P., Ali, Ayesha S., McIlroy, Graham, Thust, Steffi, Martinez-Calle, Nicolás, Jackson, Aimee E., Hopkins, Louise M., Thomas, Catherine M., Kassam, Shireen, Wright, Josh, Chaganti, Sridhar, Smith, Jeffery, Chau, Ian, Culligan, Dominic, Linton, Kim M., Collins, Graham P., Ferreri, Andrés J. M., Lewis, David, Davies, Andrew J., Johnson, Rod, Auer, Dorothee P., Cwynarski, Kate
Publicado 2021

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

por Li, Yong, Xu-Monette, Zijun Y., Abramson, Jeremy, Sohani, Aliyah R., Bhagat, Govind, Tzankov, Alexandar, Visco, Carlo, Zhang, Shanxiang, Dybkaer, Karen, Pan, Zenggang, Xu, Min, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Go, Heounjeong, van Krieken, J. Han, Winter, Jane N., Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Piris, Miguel A., Wang, Yingjun, Zhang, Mingzhi, Young, Ken H.
Publicado 2022